These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10136037)

  • 1. Lessons from America's fastest-growing companies.
    Serwer AE
    Fortune; 1994 Aug; 130(3):42-5, 48-51, 54 passim. PubMed ID: 10136037
    [No Abstract]   [Full Text] [Related]  

  • 2. America's 100 fastest-growing companies.
    Teitelbaum RS
    Fortune; 1995 Apr; 131(7):74-6, 80, 84 passim. PubMed ID: 10144014
    [No Abstract]   [Full Text] [Related]  

  • 3. America's fastest risers.
    Deutschman A
    Fortune; 1991 Oct; 124(8):46-8, 50, 54-5 passim. PubMed ID: 10114430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-care companies stampede onto Wall Street.
    Med Econ; 1997 Jan; 74(1):22. PubMed ID: 10164331
    [No Abstract]   [Full Text] [Related]  

  • 5. Fortune 500 ranked by performance.
    Fortune; 1997 Apr; 135(8):F27-31. PubMed ID: 10166667
    [No Abstract]   [Full Text] [Related]  

  • 6. Fortune 500 medians.
    Fortune; 1997 Apr; 135(8):F24-6. PubMed ID: 10166666
    [No Abstract]   [Full Text] [Related]  

  • 7. Fortune 500 ranked within states.
    Fortune; 1997 Apr; 135(8):F32-43. PubMed ID: 10166668
    [No Abstract]   [Full Text] [Related]  

  • 8. Healthcare stocks still strong but no match for 1995.
    Lutz S
    Mod Healthc; 1996 Jul; 26(29):2. PubMed ID: 10158827
    [No Abstract]   [Full Text] [Related]  

  • 9. Fortune 500 largest U.S. corporations.
    Fortune; 1997 Apr; 135(8):F1-23. PubMed ID: 10166665
    [No Abstract]   [Full Text] [Related]  

  • 10. Fortune 1,000 ranked within industries.
    Fortune; 1997 Apr; 135(8):F44-70. PubMed ID: 10166669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Medicare reform on managed care.
    Derrell R
    Manag Care Interface; 1999 Aug; 12(8):42-3. PubMed ID: 10621091
    [No Abstract]   [Full Text] [Related]  

  • 12. Ahead of the curve. Staying one step ahead of the market pays off for IHS.
    Thayer L
    Contemp Longterm Care; 1998 Mar; 21(3):78-9, 81-3. PubMed ID: 10177831
    [No Abstract]   [Full Text] [Related]  

  • 13. Stock market successes and HMO growing pains.
    Gemignani J
    Bus Health; 1998 Apr; 16(4):35-6, 38-9. PubMed ID: 10178400
    [No Abstract]   [Full Text] [Related]  

  • 14. Finance. Healthy gains.
    Hosp Health Netw; 1997 Sep; 71(18):12. PubMed ID: 9354149
    [No Abstract]   [Full Text] [Related]  

  • 15. Monstrous problems. Medicare's not the only bogeyman haunting the long-term-care industry.
    Saphir A
    Mod Healthc; 1999 Jul; 29(30):30-3. PubMed ID: 10539350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality care. Do the bull and the bear affect health care?
    Med Econ; 1998 May; 75(9):38. PubMed ID: 10180436
    [No Abstract]   [Full Text] [Related]  

  • 17. Insider trading in health care companies: 1988 and 1987.
    Palkon DS
    Contemp Longterm Care; 1989 May; 12(6):101-2. PubMed ID: 10304379
    [No Abstract]   [Full Text] [Related]  

  • 18. Quarterly financial results of post acute/subacute companies.
    Natl Rep Subacute Care; 1999 Mar; 7(5):6. PubMed ID: 10351011
    [No Abstract]   [Full Text] [Related]  

  • 19. Cowen's post-acute stock price index.
    Natl Rep Subacute Care; 1997 Mar; 5(5):8. PubMed ID: 10165659
    [No Abstract]   [Full Text] [Related]  

  • 20. Finance. Sluggish stocks.
    Hosp Health Netw; 1998 Sep; 72(17):12. PubMed ID: 9771426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.